121 related articles for article (PubMed ID: 22806275)
1. About the discrepancies between consensus documents, clinical practice guidelines, and legal regulations in the treatment of type 2 diabetes.
Martínez-Castelao A; Górriz JL; Sola E; Morillas C; Jover A; Coronel F; Navarro-González J; De Álvaro F
Nefrologia; 2012 Jul; 32(4):419-26. PubMed ID: 22806275
[No Abstract] [Full Text] [Related]
2. Discrepancies between the summary of characteristics and the recommended use of metformin in the treatment of type 2 diabetes mellitus patients.
del Pozo-Fernández C; Pardo-Ruiz C; Sánchez-Botella C; López-Menchero R
Nefrologia; 2012; 32(6):837-8; author reply 388-9. PubMed ID: 23169370
[No Abstract] [Full Text] [Related]
3. Antidiabetics in chronic kidney disease: new questions to new and classical drugs.
Serra-Tarragón J
Nefrologia; 2012; 32(6):835; author reply 835-7. PubMed ID: 23169369
[No Abstract] [Full Text] [Related]
4. Discrepancies among consensus documents, guidelines, clinical practice and the legal framework for the treatment of type 2 diabetes mellitus patients.
del Pozo-Fernández C; Pardo-Ruiz C; Sánchez-Botella C; Blanes-Castañer V; López-Menchero R; Gisbert-Sellés C; Sánchez-Jodar C; Alvarez-Avellán L
Nefrologia; 2012 May; 32(3):367-73. PubMed ID: 22592422
[TBL] [Abstract][Full Text] [Related]
5. [Status of glitazones in treatment of type 2 diabetes mellitus].
Willeke A
Internist (Berl); 2007 Jul; 48(7):749; author reply 749-50. PubMed ID: 17571246
[No Abstract] [Full Text] [Related]
6. The impact of publishing medical specialty society guidelines on subsequent adoption of best practices: a case study with type 2 diabetes.
Huang EA; Zdon GS; Moore RJ; Jane Moran H; Quick WW
Int J Clin Pract; 2010 Apr; 64(5):558-61. PubMed ID: 20456210
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of guidelines on diabetes medication.
Giaccari A; Giorda CB; Riccardi G; De Micheli A; Bruno G; Monge L; Frontoni S
Ann Intern Med; 2012 May; 156(10):752-3; author reply 753. PubMed ID: 22586015
[No Abstract] [Full Text] [Related]
8. Evaluation of guidelines on diabetes medication.
Brown K; Harbour R; Petrie J
Ann Intern Med; 2012 May; 156(10):752; author reply 753. PubMed ID: 22586014
[No Abstract] [Full Text] [Related]
9. Diabetes: Metformin and renal insufficiency-is 45, or even 30, the new 60?
Bloomgarden Z
Nat Rev Endocrinol; 2015 Dec; 11(12):693-4. PubMed ID: 26416220
[No Abstract] [Full Text] [Related]
10. [Some considerations on the Consensus of the Spanish Diabetes Society and the Spanish Society of Family and Community Medicine on the criteria and guidelines for combined therapy for type 2 diabetes].
González-Clemente JM; Giménez-Pérez G; Caixàs A; Mauricio D
Aten Primaria; 2001 Nov; 28(9):624-5. PubMed ID: 11747781
[No Abstract] [Full Text] [Related]
11. [Metformin is also recommended in mild and moderate renal failure].
Zechmann S
Praxis (Bern 1994); 2015 Mar; 104(7):370-1. PubMed ID: 25804780
[No Abstract] [Full Text] [Related]
12. Diabetes in the new General Medical Services contract: targets and adherence to metformin therapy.
Kirby M
Int J Clin Pract; 2005 Mar; 59(3):263-6. PubMed ID: 15857318
[No Abstract] [Full Text] [Related]
13. The renaissance of metformin in endocrine clinical practice.
Milewicz A; Sieradzki J; Tendera-Małecka E; Skałba P; Jedrzejuk D
Gynecol Endocrinol; 2009 May; 25(5):277-81. PubMed ID: 19903035
[No Abstract] [Full Text] [Related]
14. [Guideline: type 2 diabetes mellitus therapy: metformin, a critical perspective].
Pinto D; Heleno B; Gallego R; Santos I; Santiago LM; Maria V
Acta Med Port; 2011; 24(2):331-8. PubMed ID: 22011607
[TBL] [Abstract][Full Text] [Related]
15. Metformin in 2019.
Flory J; Lipska K
JAMA; 2019 May; 321(19):1926-1927. PubMed ID: 31009043
[TBL] [Abstract][Full Text] [Related]
16. Renal status among patients using metformin in a primary care setting.
Kennedy L; Herman WH;
Diabetes Care; 2005 Apr; 28(4):922-4. PubMed ID: 15793196
[No Abstract] [Full Text] [Related]
17. Prescribing of metformin based on estimated GFR rather than serum creatinine expands the eligible population and is likely safe.
Castelino RL; Peterson G
Evid Based Med; 2016 Apr; 21(2):68. PubMed ID: 26786825
[No Abstract] [Full Text] [Related]
18. Glycemic Therapy for Type 2 Diabetes: Choices Expand, Data Lag Behind.
Fradkin JE; Rodgers GP
Ann Intern Med; 2017 Feb; 166(4):309-310. PubMed ID: 28055042
[No Abstract] [Full Text] [Related]
19. [Metformin and kidney].
Sessa C; Blanco J; Granata A; Fatuzzo P; Castellino P; Zanoli L
G Ital Nefrol; 2016; 33(3):. PubMed ID: 27374392
[TBL] [Abstract][Full Text] [Related]
20. Policies, Guidelines and Consensus Statements: Pharmacologic Management of Type 2 Diabetes-2015 Interim Update.
; Harper W; Clement M; Goldenberg R; Hanna A; Main A; Retnakaran R; Sherifali D; Woo V; Yale JF; Cheng AY;
Can J Diabetes; 2015 Aug; 39(4):250-2. PubMed ID: 26233723
[No Abstract] [Full Text] [Related]
[Next] [New Search]
